Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: A single institutional experience

Journal of Radiation Research

Volumn 54, Issue 1, 2013, Pages 108-112

  Shioyama, Yoshiyuki ^a   Nakamura, Katsumasa ^a   Sasaki, Tomonari ^a   Ohga, Saiji ^a   Yoshitake, Tadamasa ^a   Nonoshita, Takeshi ^a   Asai, Kaori ^a   Terashima, Koutarou ^a   Matsumoto, Keiji ^a   Hirata, Hideki ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

small cell lung cancer; Stage I; stereotactic body radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; DISEASES; RADIOTHERAPY; SURGERY; TUMORS;

4-CYCLE; CARBOPLATIN; ETOPOSIDE; LUNG TUMOR; NON-COPLANAR; PULMONARY FUNCTION; SMALL-CELL LUNG CANCER; STAGE I; STEREOTACTIC BODY RADIOTHERAPY; TREATMENT OUTCOMES;

CHEMOTHERAPY;

EID: 84872010147     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs075     Document Type: Article

References (21)

1. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-96.
2. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890-5.
3. Johnson BE, Crawford J, Downey RJ et al. Small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006;4:602-22.
4. The Japan Lung Cancer Society: Japan and Chiba. http://www.haigan.gr.jp/ uploads/photos/261.pdf (20 January 2011, date last accessed, in Japanese).
5. Wulf J, Haedinger U, Oppitz U et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-96.
6. Onishi H, Araki T, Shirato H et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31.
7. Singh D, Yi WS, Brasacchio RA et al. Is there a favorable subset of patients with prostate cancer who develop oligometastases? Int J Radiat Oncol Biol Phys 2004;58:3-10.
8. Nagata Y, Takayama K, Matsuo Y et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63: 1427-31.
9. Zimmermann FB, Geinitz H, Schill S et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005;48:107-14.
10. Shioyama Y, Nakamura K, Anai S et al. Stereotactic radiotherapy for lung and liver tumors using a body cast system: Setup accuracy and preliminary clinical outcome. Radiat Med 2005;23:407-13.
11. Yoshitake T, Nakamura K, Shioyama Y et al. Breath-Hold monitoring and visual feedback for radiotherapy using a charge-coupled device camera and a head-Mounted display: System development and feasibility. Radiat Med 2008;26: 50-5.
12. Yoshitake T, Shioyama Y, Nakamura K et al. A clinical evaluation of visual feedback-guided breath-Hold reproducibility of tumor location. Phys Med Biol 2009;54:7171-82.
13. Cancer Therapy Evaluation Program NCI; Common Terminology Criteria for Adverse events (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev3.pdf (9 August 2006, date last accessed).
14. Davis S, Crino L, Tonato M et al. A prospective analysis of chemotherapy following surgical resection of clinical stage I-II small-cell lung cancer. Am J Clin Ocol 1993;16:93-5.
15. Rea F, Callegaro D, Favaretto A et al. Long term results of surgery and chemotherapy in small cell lung cancer. Eur J Cardio-thorac Surg 1998;14:398-402.
16. Brock MV, Hooker CM, Syphard JE et al. Surgical resection of limited disease SCLC in the new era of platinum chemotherapy; its time has come. J Thorac Cardiovasc Surg 2005;129:64-72.
17. Tsuchiya R, Suzuki K, Ichinose Y et al. Phase II trial of postoperative adjuvant cisplatin and etoposside in patients with completely resected stage IIIIA small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 2005;129:977-83.
18. Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398-403.
19. Shibamoto Y, Otsuka S, Iwata H et al. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: Effect of prolonged delivery time and applicability of the linear-quadratic model. J Radiat Res 2012;53:1-9.
20. Aupérin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-84.
21. Le Péchoux CL, Dunant A, Senan S et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004,RTOG 0212, and IFCT 99-01): A randomised clinical trial. Lancet Oncol 2009;10: 467-74.